E4786

Escitalopram -oxalat (Salz)

≥98% (HPLC), powder, serotonin reuptake inhibitor

• Synonym(e): (S)-(+)-1-[3-(Dimethylamino)-propyl]-1-(4-fluorphenyl)-1,3-dihydro-5-isobenzofurancarbonitril -oxalat (Salz), (S)-(+)-Citalopram -oxalat (Salz)
• Empirische Formel (Hill-System): C₂₀H₂₁FN₂O · C₂H₂O₄
• CAS-Nummer: 219861-08-2
• Molekulargewicht: 414.43
• MDL-Nummer: MFCD06407826
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329799062
• NACRES: NA.77

Eigenschaften

• product name: Escitalopram -oxalat (Salz), ≥98% (HPLC), powder
• Assay: ≥98% (HPLC)
• Form: powder
• Lagerbedingungen: desiccated
• Farbe: white to tan
• Löslichkeit: DMSO: ≥15 mg/mL
• Ersteller: Forest Labs
• Lagertemp.: 2-8°C
• SMILES String: OC(=O)C(O)=O.CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3
• InChI: 1S/C20H21FN2O.C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;3-1(4)2(5)6/h4-9,12H,3,10-11,14H2,1-2H3;(H,3,4)(H,5,6)/t20-;/m0./s1
• InChIKey: KTGRHKOEFSJQNS-BDQAORGHSA-N
• Angaben zum Gen: human ... SLC6A4(6532)

Beschreibung

Allgemeine Beschreibung

Escitalopram oxalate is an anti-depressant. It is used to treat panic disorder and major depressive disorder(MDD).

Anwendung

Escitalopram oxalate has been used as an antidepressant in rats exposed to chronic mild stress (CMS). It has also been used for scintillation proximity-based thermostability assay.

Biochem./physiol. Wirkung

Escitalopram is a selective serotonin reuptake inhibitor (SSRI), the S-enantiomer and eutomer of citalopram.

Leistungsmerkmale und Vorteile

This compound was developed by Forest Labs. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302 + H312
• P-Sätze: P264 - P280 - P301 + P312 - P302 + P352 + P312 - P362 + P364 - P501
• Gefahreneinstufungen: Acute Tox. 4 Dermal - Acute Tox. 4 Oral
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable